Dubai PR Network, Online Press Release from Dubai and Middle East
 
Medicine, Laboratory & Treatment(Healthcare & Medicine)
Filter PR by
  
Julphar to Launch Wearable Insulin Delivery Device in GCC
 
Julphar to Launch Wearable Insulin Delivery Device in GCC
  • Exclusive distribution agreement signed with US medical technology company, Valeritas
  • ‘High-tech device will help empower diabetes sufferers to take control of their condition,’ says Julphar GM

December 12, 2018, Ras Al Khaimah (UAE) -   Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has signed an exclusive distribution agreement with medical technology company Valeritas Holdings, Inc. to bring its V-Go® Wearable Insulin Delivery device to the GCC.  

The device is an all-in-one, wearable insulin delivery option for patients with diabetes. Under the terms of the agreement, Julphar will have the rights to promote, market and sell the product to diabetes clinics and patients in the GCC. Julphar will be responsible for all sales, marketing, customer support and distribution activities in the region while Valeritas will retain responsibility for product development, regulatory approval, quality management and manufacturing.

Commenting on the announcement, Jerome Carle, General Manager of Julphar, said, “The prevalence of diabetes in the GCC is among the highest in the world. As a leader in the manufacture of insulin, Julphar has a responsibility to not only raise awareness of the risk factors but to provide effective solutions. 

“We are always exploring new, innovative and affordable options such as mobile tech, wearables and other tools, so partnering with Valeritas to bring the wearable V-Go® to the region made perfect sense. The high-tech device will help empower diabetes sufferers to take control of their condition and manage their own day-to-day care.”

With today’s announcement, Valeritas now has V-Go® distribution agreements in place covering 14 countries and territories. In addition to the Middle East countries, executed distribution agreements include Australia, Austria, the Czech Republic, Germany, Italy, Puerto Rico, Slovenia, and New Zealand.  Separately, Valeritas recently announced it has started the process to gain regulatory approval for V-Go® in China. 

John Timberlake, CEO and President of Valeritas, said: “Diabetes is now a worldwide epidemic. Currently, 425 million people suffer with diabetes, and that number is expected to grow to 629 million.

“For many patients with diabetes around the world, being able to adhere to a daily insulin routine of multiple injections using insulin pens and syringes is a significant challenge. Valeritas has consistently demonstrated in clinical studies that patients who switched from injection therapy to the wearable V-Go® significantly lowered blood glucose and used less insulin. 

“V-Go® is discrete, simple-to-use, cost-effective, clinically proven, and the only disposable, daily insulin delivery option available today. Partnering with Julphar, we are excited with the prospect of making V-Go® available to diabetes patients in the GCC.”  


Posted by : Dubai PR Network Editorial Team
Viewed 11846 times
PR Category : Healthcare & Medicine
Posted on : Wednesday, December 12, 2018  9:32:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : RAK Hospitality Holding Signs MoU with Beit Al Khair Societ...
Next Story : Listen to the Autism Beat Gala Dinner at Atlantis - The Palm
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Police Is the Official Eyewear in Sony Pictures' “men in Black™: International” [7485-Views]
Michael Kors Celebrates Old Bond Street Townhouse With a Series of Events [6448-Views]
Discover the irresistible La Yuqawam Pour Femme Fragrance [6332-Views]
Make their Eid special this year with these perfect gifts! [5478-Views]
An essential guide to buying fragrance [5398-Views]
Eid Gift Guide Options [5142-Views]
Flormar's Three Beauty Essentials for Ramadan Nights [4892-Views]
Rado True Thinline My Bird Limited Edition' [4715-Views]
Gift your loved ones a fragrance to remember this Eid by Rasasi Perfumes [4660-Views]
SPF Must Haves – for everyday sun exposure! [4587-Views]
TAG Heuer launches 2 special editions to commemorate Indy 500 race - Carrera and Formula 1 [4575-Views]
Tissot Chrono XL NBA Collector' [4459-Views]
Salvatore Ferragamo Timepieces – Spring/Summer 2019 Collection' [4453-Views]
6,000 worshippers prayed with Sheikh Saad bin Said Al-Ghamdi at Grand Mosque of Rashidiya ... [4343-Views]
Chronoswiss Flying Regulator Night and Day Limited Edition [4142-Views]
Carl F. Bucherer celebrates premiere of John Wick: Chapter 3 – Parabellum in New Yo... [4038-Views]
HONOR Has Got You Covered This Eid With Multiple Gifting Options [3983-Views]
First Five Cities Revealed for New Call of Duty Esports League [3959-Views]
MOUAWAD: Wedding Sets 2019 [3934-Views]
Longchamp Eyewear Introduces a New Sunglass Style Featuring the Brand's Signature Stripe ... [3886-Views]
The Ultimate Eid Gift Guide [3630-Views]
Surprise beat Dubai 2020 to reach NAS Volleyball semis, meet Bin Thani next [3508-Views]
Shop the new Elna Line Collection at The Edit [3489-Views]
Karl Lagerfeld and Puma Introduce Two Special-Edition Sneakers [3453-Views]
Parmigiano Reggiano Exports to Gcc Region Soars to 105.2 Tons [3428-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories